We report that p53 up-regulated antioxidant proteins and the negatively regulated mTOR pathway indicate a N3a-induced metabolic shift in lymphomas, decreasing glycolytic flux and enhancing OxPhos, a metabolic adaptation linked to p53′s role as a metabolic regulator that can be targeted for therapeutic intervention. The gene discussed is MTOR; the disease is lymphoma.